33747-09-0

Basic information

• Product Name: 2,6-Dimethyltetrahydro-2H-pyran-4-ol
• Synonyms: 2,6-Dimethyltetrahydro-2H-pyran-4-ol;2,6-Dimethyl-tetrahydro-pyran-4-ol
• CAS NO: 33747-09-0
• Molecular Formula: C₇H₁₄O₂
• Molecular Weight: 130.18486
• Mol File: 33747-09-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,6-Dimethyltetrahydro-2H-pyran-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,6-Dimethyltetrahydro-2H-pyran-4-ol(33747-09-0)
• EPA Substance Registry System: 2,6-Dimethyltetrahydro-2H-pyran-4-ol(33747-09-0)

Safety Data

• Hazardous Substances Data: 33747-09-0(Hazardous Substances Data)

Usage

General Description

2,6-Dimethyltetrahydro-2H-pyran-4-ol is a chemical compound with a molecular formula C8H16O2. It is a cyclic ether alcohol, commonly known as a pyran. 2,6-Dimethyltetrahydro-2H-pyran-4-ol is found in certain natural products and is also used in the production of perfumes and flavoring agents. Its unique structure and properties make it valuable in various industrial applications. It is important to handle this compound with care, as it can irritate the skin and respiratory system if proper precautions are not taken.

Upstream product

• 1004-36-0 2,6-dimethylpyrone 
• 64-17-5 ethanol 
• 100719-26-4 4-nitro-benzoic acid-(2r,6c-dimethyl-tetrahydro-pyran-4t-yl ester) 
• 33747-09-0 (2R,4S,6S)-2,6-dimethyltetrahydro-2H-pyran-4-ol 
• 752244-29-4 (2R,6S)-2,6-dimethyltetrahydro-4H-pyran-4-one 
• 111957-98-3 Pent-4-en-2-ol 
• 123-38-6 propionaldehyde 

Downstream Products

• 1306729-81-6 C₁₄H₂₀O₄S 
• 100719-26-4 4-nitro-benzoic acid-(2r,6c-dimethyl-tetrahydro-pyran-4t-yl ester) 
• 33747-09-0 2r,6c-Dimethyl-tetrahydro-pyran-4t-ol 
• 1306729-82-7 C₂₉H₃₁NO₃ 
• 1306729-83-8 C₁₈H₂₅NO₅ 
• 1306785-92-1 C₁₄H₂₀O₄S 
• 1393537-49-9 dimethyl (4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl((2S,5S)-5-methyl-2,1-pyrrolidinediyl)((1S)-1-((2R,4r,6S)-2,6-dimethyltetrahydro-2H-pyran-4-yl)-2-oxo-2,1-ethanediyl)))biscarbamate 

Relevant articles and documents

INHIBITOR OF BTK AND MUTANTS THEREOF

The disclosure includes compounds of Formula (I) (1) wherein Q0, Q1, Q2, Q3, Q4, Z, W, i, j, m, n, Warhead, R0, R1, R3, R4, R5, R6, and R7, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.

THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

Thiophene-substituted tetracyclic compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein A, A', R2, R3, R4 and R5 are as defined herein. The compositions comprising at least one thiophene-substituted tetracyclic compound, and methods of using the thiophene-substituted tetracyclic compounds for treating or preventing HCV infection in a patient are also provided.